BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 29066974)

  • 1. Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms.
    Soderstrom K; Soliman E; Van Dross R
    Front Pharmacol; 2017; 8():720. PubMed ID: 29066974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.
    Zhou H; Peng X; Hou T; Zhao N; Qiu M; Zhang X; Liang X
    J Ethnopharmacol; 2020 Jan; 246():112218. PubMed ID: 31494202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in
    Oakes M; Law WJ; Komuniecki R
    J Neurosci; 2019 May; 39(21):4142-4152. PubMed ID: 30886012
    [No Abstract]   [Full Text] [Related]  

  • 8. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
    Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
    Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS.
    Onaivi ES
    Curr Neuropharmacol; 2011 Mar; 9(1):205-8. PubMed ID: 21886591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
    López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
    Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions and Regulation of Ionotropic Cannabinoid Receptors.
    De Petrocellis L; Nabissi M; Santoni G; Ligresti A
    Adv Pharmacol; 2017; 80():249-289. PubMed ID: 28826537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of Entourage: Terpenoids Commonly Found in
    Santiago M; Sachdev S; Arnold JC; McGregor IS; Connor M
    Cannabis Cannabinoid Res; 2019; 4(3):165-176. PubMed ID: 31559333
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects.
    Mendiguren A; Aostri E; Pineda J
    Life Sci; 2018 Jan; 192():115-127. PubMed ID: 29169951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and cannabinoids: pharmacology and therapeutic potential.
    Śmiarowska M; Białecka M; Machoy-Mokrzyńska A
    Neurol Neurochir Pol; 2022; 56(1):4-13. PubMed ID: 35133644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids and cannabinoid receptor genetics.
    Onaivi ES; Leonard CM; Ishiguro H; Zhang PW; Lin Z; Akinshola BE; Uhl GR
    Prog Neurobiol; 2002 Apr; 66(5):307-44. PubMed ID: 12015198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanism and Cannabinoid Pharmacology.
    Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
    Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors.
    Gertsch J; Raduner S; Altmann KH
    J Recept Signal Transduct Res; 2006; 26(5-6):709-30. PubMed ID: 17118807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid CB
    Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
    Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission.
    Kim J; Li Y
    J Physiol; 2015 Feb; 593(4):871-86. PubMed ID: 25504573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.